Recurrent Grade 3 Follicular Lymphoma Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Recruiting
- Recurrent Chronic Lymphocytic Leukemia
- +17 more
- Nivolumab
- Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
2022-02-28
Feb 28, 2022N
Completed
- AIDS-Related Plasmablastic Lymphoma
- +15 more
- Cyclophosphamide
- +8 more
- Montgomery, Alabama
- +34 more
2022-02-23
Feb 23, 2022N
Suspended
- Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
- +25 more
- Blinatumomab
- Lenalidomide
- Birmingham, Alabama
- +23 more
2022-03-05
Mar 5, 2022C
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia
- +125 more
- tetanus-CMV fusion peptide vaccine
- laboratory biomarker analysis
- Duarte, CaliforniaCity of Hope Medical Center
2022-02-28
Feb 28, 2022C
Recruiting
- Recurrent B-Cell Non-Hodgkin Lymphoma
- +19 more
- CpG-STAT3 siRNA CAS3/SS3
- Radiation Therapy
- Duarte, CaliforniaCity of Hope Medical Center
2022-02-28
Feb 28, 2022C
Active, not recruiting
- Adult Grade III Lymphomatoid Granulomatosis
- +23 more
- autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
- +2 more
- Duarte, CaliforniaCity of Hope Medical Center
2022-02-16
Feb 16, 2022M
Active, not recruiting
- Grade 3a Follicular Lymphoma
- +9 more
- Laboratory Biomarker Analysis
- +2 more
- Houston, TexasM D Anderson Cancer Center
2022-02-09
Feb 9, 2022M
Active, not recruiting
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +20 more
- panobinostat
- +6 more
- Scottsdale, Arizona
- +1 more
2022-02-03
Feb 3, 2022C
Active, not recruiting
- Recurrent Grade 1 Follicular Lymphoma
- +4 more
- Autologous Hematopoietic Stem Cell Transplantation
- +6 more
- Duarte, CaliforniaCity of Hope Comprehensive Cancer Center
2021-11-22
Nov 22, 2021N
Active, not recruiting
- Grade 3a Follicular Lymphoma
- +4 more
- Ibrutinib
- Laboratory Biomarker Analysis
- Scottsdale, Arizona
- +12 more
2021-12-15
Dec 15, 2021O
Active, not recruiting
- Hematopoietic Cell Transplantation Recipient
- +11 more
- Carmustine
- +5 more
- Columbus, OhioOhio State University Comprehensive Cancer Center
2021-09-29
Sep 29, 2021K
Active, not recruiting
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +8 more
- PI3K inhibitor BKM120
- +3 more
- Atlanta, Georgia
- +1 more
2021-09-29
Sep 29, 2021N
Terminated
- Adult Grade III Lymphomatoid Granulomatosis
- +116 more
- brentuximab vedotin
- +2 more
- Chicago, Illinois
- +2 more
2021-08-30
Aug 30, 2021S
Recruiting
- Accelerated Phase Chronic Myelogenous Leukemia
- +67 more
- Fludarabine phosphate
- +8 more
- Philadelphia, PennsylvaniaThomas Jefferson University
2021-08-31
Aug 31, 2021M
Active, not recruiting
- Recurrent B-Cell Non-Hodgkin Lymphoma
- +22 more
- Ibrutinib
- +3 more
- Scottsdale, Arizona
- +1 more
2021-08-10
Aug 10, 2021B
Completed
- Adult Grade III Lymphomatoid Granulomatosis
- +88 more
- bortezomib
- +2 more
- Detroit, MichiganBarbara Ann Karmanos Cancer Institute
2021-04-14
Apr 14, 2021R
Completed
- Adult Acute Lymphoblastic Leukemia in Remission
- +58 more
- etoposide
- +9 more
- Buffalo, New YorkRoswell Park Cancer Institute
2021-03-23
Mar 23, 2021F
Terminated
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +32 more
- indium In 111 anti-CD45 monoclonal antibody BC8
- +2 more
- Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
2021-03-07
Mar 7, 2021K
Active, not recruiting
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +9 more
- BTK inhibitor PCI-32765
- +5 more
- Columbus, OhioOhio State University Medical Center
2021-02-20
Feb 20, 2021F
Completed
- Hematopoietic/Lymphoid Cancer
- +135 more
- beclomethasone dipropionate
- +4 more
- Hackensack, New Jersey
- +1 more
2021-02-01
Feb 1, 2021N
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +35 more
- Akt inhibitor MK2206
- laboratory biomarker analysis
- Houston, TexasM D Anderson Cancer Center
2020-10-14
Oct 14, 2020M
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +18 more
- everolimus
- +6 more
- Scottsdale, Arizona
- +1 more
2020-09-28
Sep 28, 2020C
Completed
- Hematopoietic/Lymphoid Cancer
- +22 more
- anti-CD19/20-CAR vector-transduced T cells
- Beijing, Beijing, ChinaBiotherapeutic Department and Pediatrics Department of Chinese P
2020-08-31
Aug 31, 2020N
Completed
- Anaplastic Large Cell Lymphoma
- +12 more
- Laboratory Biomarker Analysis
- Tipifarnib
- Iowa City, Iowa
- +1 more
2020-04-03
Apr 3, 2020M
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +27 more
- panobinostat
- +3 more
- Scottsdale, Arizona
- +2 more
2020-03-02
Mar 2, 2020